Lysine (Immune).

Lysine and arginine are both cationic amino acids carried by the same y+ transport system in the gut and at the cell membrane, so a high dose of one lowers uptake of the other. This antagonism is settled transport pharmacology.

Ornithine is the third basic amino acid on the y+ carrier, so it competes with lysine for the same transport sites. Large simultaneous doses reduce each other's absorption.

Lysyl hydroxylase converts lysine residues to hydroxylysine during collagen assembly and requires ascorbate to keep its iron centre reduced. Lysine supplies the residue and vitamin C enables the modification.

Both lysyl hydroxylase and the carnitine-forming hydroxylases downstream of lysine are iron-dependent dioxygenases. Iron status therefore limits what lysine can be converted into.

Lysine has been reported to increase intestinal calcium uptake and reduce its urinary loss, which is why the two appear together in bone formulas. The effect is reported at gram-level lysine intakes.

Collagen chains contain lysine and hydroxylysine residues that form the crosslinks holding fibrils together. Lysine is one of the amino acids collagen synthesis draws on.

Carnitine is synthesised from trimethylated lysine residues, so lysine is its carbon source. Supplying carnitine directly removes the need for that conversion.

Pyridoxal phosphate serves the transamination step in the conversion of trimethyllysine toward carnitine and in lysine catabolism generally. B6 status shapes how lysine is routed.

Lysyl oxidase is a copper-dependent enzyme, and it acts on lysine residues already built into collagen and elastin to form the cross-links that give connective tissue its tensile behaviour. Without adequate copper at the enzyme, the lysine substrate is present but the cross-linking step runs slowly. This is settled enzymology rather than a tested supplement pairing.

Biotin is attached covalently to a single specific lysine residue on each of the human carboxylases, forming biocytin. The lysine side chain is the anchor point that lets the vitamin do its carboxyl-transfer work. Lysine is not limiting for this in ordinary diets, so the relationship is mechanistic rather than a reason to dose the two together.

Lysine, arginine, ornithine and histidine all move across the intestinal and renal brush border on cationic amino acid carriers of the y+ family. Large single doses of one cationic amino acid slow the uptake of the others while the carrier is occupied. Spacing the doses is the usual formulation answer.

Carnitine synthesis starts from protein-bound lysine that has been methylated three times, and every one of those methyl groups comes from S-adenosylmethionine generated from methionine. Lysine supplies the carbon skeleton and methionine supplies the methyl groups. Both have to be adequate for the pathway to run at normal rates.

S-adenosylmethionine is the direct methyl donor that converts protein-bound lysine into trimethyllysine, the committed first step toward carnitine. The reaction consumes one SAM per methyl transfer. This is a biochemical dependency, not a clinical combination that has been trialled.

Betaine regenerates methionine from homocysteine, which keeps the S-adenosylmethionine pool topped up. That pool is what methylates lysine residues on the way to carnitine and on histones and tubulin generally. The link to lysine is one step removed and belongs in the mechanistic column.

Collagen is built on a repeating glycine-proline-hydroxyproline pattern with lysine and hydroxylysine at the cross-linking positions. Supplying the amino acid pattern the protein actually uses is standard formulation reasoning for connective tissue support. It says nothing about how much collagen a person will make.

Proline and lysine are the two residues that get hydroxylated in collagen, by prolyl and lysyl hydroxylase respectively, and both enzymes need ascorbate and iron. Formulators pair them because they occupy complementary positions in the same protein. The pairing is compositional logic, not a measured additive effect.

Pyridoxal 5-phosphate forms a Schiff base with the epsilon-amino group of an active-site lysine in every PLP-dependent enzyme, and it is also the cofactor for saccharopine dehydrogenase steps in lysine catabolism. Lysine is both the anchor for the cofactor and a substrate downstream of it. Pyridoxal phosphate is the largest single co-occurring entity in the lysine literature for exactly this reason.

Lysine forms stable one-to-one and two-to-one chelates with divalent minerals, and zinc lysinate is one of the mineral amino acid chelate forms sold on that basis. The amino acid acts as a carrier ligand rather than as an active in that role. Chelation changes the mineral's solubility profile; it is not evidence that more zinc reaches tissue.

Both amino acids are used heavily by rapidly dividing tissue, including the gut lining and the cells of immune organs, and both are common in free amino acid blends aimed at protein turnover. Lysine is indispensable and glutamine is conditionally so, which is why they appear together in low-protein diet studies. The pairing is nutritional rather than a demonstrated interaction.